drospirenone and ethinyl estradiol combination has been researched along with citalopram in 1 studies
| Studies (drospirenone and ethinyl estradiol combination) | Trials (drospirenone and ethinyl estradiol combination) | Recent Studies (post-2010) (drospirenone and ethinyl estradiol combination) | Studies (citalopram) | Trials (citalopram) | Recent Studies (post-2010) (citalopram) |
|---|---|---|---|---|---|
| 130 | 51 | 102 | 5,348 | 1,424 | 2,350 |
| Protein | Taxonomy | drospirenone and ethinyl estradiol combination (IC50) | citalopram (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.297 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.196 | |
| Aromatase | Rattus norvegicus (Norway rat) | 0.0018 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.196 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.289 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.297 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0227 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0027 | |
| Histamine H1 receptor | Homo sapiens (human) | 3.194 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.839 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1869 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.398 | |
| Transporter | Rattus norvegicus (Norway rat) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourke, J; Roper, S | 1 |
1 other study(ies) available for drospirenone and ethinyl estradiol combination and citalopram
| Article | Year |
|---|---|
In with the new: the determinants of prescribing innovation by general practitioners in Ireland.
Topics: Age Factors; Androstenes; Citalopram; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol; General Practitioners; Humans; Information Dissemination; Insurance Claim Review; Ireland; Lactones; Loratadine; Nicotine; Omeprazole; Practice Patterns, Physicians'; Residence Characteristics; Sulfones; Therapies, Investigational; Time Factors | 2012 |